[PHARMA] QoQ Annualized Quarter Result on 30-Jun-2012 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
08-Aug-2012
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
30-Jun-2012 [#2]
Profit Trend
QoQ- -22.61%
YoY- 50.99%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
Revenue 2,001,356 1,812,346 1,773,256 1,806,964 1,786,980 1,520,981 1,537,593 19.19%
PBT 147,696 103,313 132,088 141,146 171,820 73,186 75,757 55.99%
Tax -47,084 -40,108 -37,856 -50,870 -55,576 -20,401 -21,620 67.93%
NP 100,612 63,205 94,232 90,276 116,244 52,785 54,137 51.10%
-
NP to SH 99,084 61,710 92,860 88,796 114,740 52,157 53,620 50.52%
-
Tax Rate 31.88% 38.82% 28.66% 36.04% 32.35% 27.88% 28.54% -
Total Cost 1,900,744 1,749,141 1,679,024 1,716,688 1,670,736 1,468,196 1,483,456 17.95%
-
Net Worth 484,829 471,886 496,623 481,282 474,161 514,273 464,307 2.92%
Dividend
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
Div 35,303 41,187 39,227 35,301 35,297 35,304 - -
Div Payout % 35.63% 66.74% 42.24% 39.76% 30.76% 67.69% - -
Equity
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
Net Worth 484,829 471,886 496,623 481,282 474,161 514,273 464,307 2.92%
NOSH 117,676 117,677 117,683 117,672 117,657 117,682 106,983 6.55%
Ratio Analysis
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
NP Margin 5.03% 3.49% 5.31% 5.00% 6.51% 3.47% 3.52% -
ROE 20.44% 13.08% 18.70% 18.45% 24.20% 10.14% 11.55% -
Per Share
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
RPS 1,700.72 1,540.10 1,506.80 1,535.58 1,518.79 1,292.44 1,437.23 11.86%
EPS 84.20 52.44 78.91 75.46 97.52 44.32 50.12 41.27%
DPS 30.00 35.00 33.33 30.00 30.00 30.00 0.00 -
NAPS 4.12 4.01 4.22 4.09 4.03 4.37 4.34 -3.40%
Adjusted Per Share Value based on latest NOSH - 117,700
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
RPS 138.86 125.75 123.04 125.37 123.99 105.53 106.68 19.19%
EPS 6.87 4.28 6.44 6.16 7.96 3.62 3.72 50.46%
DPS 2.45 2.86 2.72 2.45 2.45 2.45 0.00 -
NAPS 0.3364 0.3274 0.3446 0.3339 0.329 0.3568 0.3222 2.91%
Price Multiplier on Financial Quarter End Date
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
Date 29/03/13 31/12/12 28/09/12 29/06/12 30/03/12 30/12/11 30/09/11 -
Price 8.26 8.10 7.55 10.18 5.90 5.36 5.90 -
P/RPS 0.49 0.53 0.50 0.66 0.39 0.41 0.41 12.60%
P/EPS 9.81 15.45 9.57 13.49 6.05 12.09 11.77 -11.42%
EY 10.19 6.47 10.45 7.41 16.53 8.27 8.49 12.92%
DY 3.63 4.32 4.42 2.95 5.08 5.60 0.00 -
P/NAPS 2.00 2.02 1.79 2.49 1.46 1.23 1.36 29.28%
Price Multiplier on Announcement Date
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
Date 15/05/13 18/02/13 06/11/12 08/08/12 03/05/12 22/02/12 01/11/11 -
Price 9.26 7.80 8.25 8.83 5.90 5.90 5.90 -
P/RPS 0.54 0.51 0.55 0.58 0.39 0.46 0.41 20.13%
P/EPS 11.00 14.87 10.46 11.70 6.05 13.31 11.77 -4.40%
EY 9.09 6.72 9.56 8.55 16.53 7.51 8.49 4.65%
DY 3.24 4.49 4.04 3.40 5.08 5.08 0.00 -
P/NAPS 2.25 1.95 1.95 2.16 1.46 1.35 1.36 39.83%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment